1. Home
  2. RNR vs RDY Comparison

RNR vs RDY Comparison

Compare RNR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNR
  • RDY
  • Stock Information
  • Founded
  • RNR 1993
  • RDY 1984
  • Country
  • RNR Bermuda
  • RDY India
  • Employees
  • RNR N/A
  • RDY N/A
  • Industry
  • RNR Property-Casualty Insurers
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNR Finance
  • RDY Health Care
  • Exchange
  • RNR Nasdaq
  • RDY Nasdaq
  • Market Cap
  • RNR 13.5B
  • RDY 13.1B
  • IPO Year
  • RNR 1995
  • RDY N/A
  • Fundamental
  • Price
  • RNR $271.96
  • RDY $14.21
  • Analyst Decision
  • RNR Buy
  • RDY Buy
  • Analyst Count
  • RNR 12
  • RDY 1
  • Target Price
  • RNR $289.50
  • RDY $17.00
  • AVG Volume (30 Days)
  • RNR 486.8K
  • RDY 827.7K
  • Earning Date
  • RNR 11-06-2024
  • RDY 11-05-2024
  • Dividend Yield
  • RNR 0.57%
  • RDY 4.05%
  • EPS Growth
  • RNR 127.60
  • RDY 4.63
  • EPS
  • RNR 69.12
  • RDY 0.76
  • Revenue
  • RNR $12,657,306,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • RNR N/A
  • RDY $13.39
  • Revenue Next Year
  • RNR $2.83
  • RDY $8.35
  • P/E Ratio
  • RNR $3.94
  • RDY $18.81
  • Revenue Growth
  • RNR 58.85
  • RDY 12.37
  • 52 Week Low
  • RNR $188.24
  • RDY $12.90
  • 52 Week High
  • RNR $300.00
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • RNR 56.29
  • RDY 37.11
  • Support Level
  • RNR $262.70
  • RDY $13.93
  • Resistance Level
  • RNR $266.94
  • RDY $14.40
  • Average True Range (ATR)
  • RNR 8.11
  • RDY 0.27
  • MACD
  • RNR 0.39
  • RDY -0.04
  • Stochastic Oscillator
  • RNR 38.07
  • RDY 18.58

About RNR RenaissanceRe Holdings Ltd.

RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: